Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
XYLAC PENDOPHARM DIVISION OF PHARMASCIENCE INC Resolved 25MG Updated Report 2024-06-01 222737
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Resolved 149MG Updated Report 2024-06-01 166363
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP PFIZER CANADA ULC Resolved 149MG Updated Report 2024-06-01 200798
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE OMEGA LABORATORIES LIMITED Resolved 20mEq Updated Report 2024-06-01 216968
APO-CABERGOLINE APOTEX INC Actual shortage 0.5MG Updated Report 2024-05-31 215982
APO-OMEPRAZOLE APOTEX INC Actual shortage 20MG Updated Report 2024-05-31 229430
APO-VARENICLINE APOTEX INC Actual shortage 0.5MG New Report 2024-05-31 229427
APO-QUETIAPINE XR APOTEX INC Actual shortage 200MG Updated Report 2024-05-31 216690
APO-MELOXICAM APOTEX INC Actual shortage 15MG New Report 2024-05-31 229422
APO-WARFARIN APOTEX INC Actual shortage 2.5MG Updated Report 2024-05-31 229419
APO-PERINDOPRIL APOTEX INC Actual shortage 8MG Updated Report 2024-05-31 229416
APO-PRAVASTATIN APOTEX INC Actual shortage 10MG New Report 2024-05-31 229413
APO-ACEBUTOLOL APOTEX INC Actual shortage 400MG New Report 2024-05-31 229410
APO-CINACALCET APOTEX INC Actual shortage 30MG New Report 2024-05-31 229407
APO-AMLODIPINE-ATORVASTATIN APOTEX INC Actual shortage 40MG 5MG New Report 2024-05-31 229404
APO-ATORVASTATIN APOTEX INC Actual shortage 40MG Updated Report 2024-05-31 229401
APO-TICAGRELOR APOTEX INC Actual shortage 60MG Updated Report 2024-05-31 229398
APO-ARIPIPRAZOLE APOTEX INC Actual shortage 15MG Updated Report 2024-05-31 229395
APO-MIRTAZAPINE APOTEX INC Actual shortage 15MG New Report 2024-05-31 229392
APO-ALLOPURINOL APOTEX INC Actual shortage 300MG Updated Report 2024-05-31 229389
APO-GLICLAZIDE APOTEX INC Actual shortage 80MG Updated Report 2024-05-31 224583
APO-GLICLAZIDE APOTEX INC Actual shortage 80MG Updated Report 2024-05-31 225799
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 100MG Updated Report 2024-05-31 227016
APO-SITAGLIPTIN MALATE APOTEX INC Actual shortage 100MG Updated Report 2024-05-31 226345
APO-BISOPROLOL APOTEX INC Actual shortage 5MG Updated Report 2024-05-31 225023
APO-VERAP TAB 80MG APOTEX INC Resolved 80MG Updated Report 2024-05-31 228810
APO-ESOMEPRAZOLE APOTEX INC Resolved 20MG Updated Report 2024-05-31 227073
APO-PANTOPRAZOLE APOTEX INC Resolved 20MG Updated Report 2024-05-31 227034
APO-LEFLUNOMIDE APOTEX INC Resolved 20MG Updated Report 2024-05-31 226315
APO-TADALAFIL APOTEX INC Resolved 2.5MG Updated Report 2024-05-31 225773
APO-SITAGLIPTIN MALATE APOTEX INC Resolved 50MG Updated Report 2024-05-31 224996
APO-SITAGLIPTIN MALATE APOTEX INC Resolved 25MG Updated Report 2024-05-31 224977
APO-SITAGLIPTIN MALATE APOTEX INC Resolved 25MG Updated Report 2024-05-31 227717
APO-GLICLAZIDE MR APOTEX INC Resolved 60MG Updated Report 2024-05-31 217481
APO-SALBUTAMOL HFA APOTEX INC Resolved 100MCG Updated Report 2024-05-31 198539
VALTREX GLAXOSMITHKLINE INC Actual shortage 500MG Updated Report 2024-05-31 229356
VALTREX GLAXOSMITHKLINE INC Actual shortage 1000MG Updated Report 2024-05-31 229353
TOBRAMYCIN FOR INJECTION FRESENIUS KABI CANADA LTD Anticipated shortage 1.2G Updated Report 2024-05-31 229350
ACH-OLMESARTAN HCTZ ACCORD HEALTHCARE INC Actual shortage 12.5MG 20MG New Report 2024-05-31 229347
ACH-AMLODIPINE ACCORD HEALTHCARE INC Actual shortage 2.5MG Updated Report 2024-05-31 214531
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 10MG Updated Report 2024-05-31 214534
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 10MG Updated Report 2024-05-31 217358
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 20MG Updated Report 2024-05-31 194733
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2024-05-31 209765
ACH-ROSUVASTATIN ACCORD HEALTHCARE INC Actual shortage 40MG Updated Report 2024-05-31 215056
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2024-05-31 224951
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Actual shortage 25MG Updated Report 2024-05-31 228605
ACH-SITAGLIPTIN ACCORD HEALTHCARE INC Actual shortage 100MG Updated Report 2024-05-31 223106
SUBLINOX BAUSCH HEALTH, CANADA INC. Anticipated shortage 10MG New Report 2024-05-31 229320
ACZONE BAUSCH HEALTH, CANADA INC. Actual shortage 5% Updated Report 2024-05-31 229317

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
BUPIVACAINE HYDROCHLORIDE INJECTION, USP STERIMAX INC Discontinued 7.5MG Updated Report 2024-06-01 216017
AVAPRO SANOFI-AVENTIS CANADA INC To be discontinued 75MG New Report 2024-05-31 229306
REPATHA AMGEN CANADA INC To be discontinued 120MG Updated Report 2024-05-24 223420
ZOVIRAX GLAXOSMITHKLINE INC Discontinued 200MG New Report 2024-05-24 228728
VITAMIN A ACID BAUSCH HEALTH, CANADA INC. Discontinued 0.01% Updated Report 2024-05-23 217835